Cite
HARVARD Citation
Mujtaba, M. et al. (n.d.). Effect of Treatment With Tabalumab, a B Cell–Activating Factor Inhibitor, on Highly Sensitized Patients With End‐Stage Renal Disease Awaiting Transplantation. American journal of transplantation. 16 (4), pp. 1266-1275. [Online].